Biomarin Pharmaceutical (BMRN) Treasury Shares (2010 - 2025)
Biomarin Pharmaceutical (BMRN) recorded quarterly Treasury Shares of $513878.0 in Q4 2025, up 20.26% on a QoQ basis from $427310.0 in Q4 2024, and up 20.26% year-over-year from $427310.0 in Q4 2024.
Biomarin Pharmaceutical (BMRN) Treasury Shares (2010 - 2025) Analysis & Trends
Biomarin Pharmaceutical has disclosed Treasury Shares across 16 years of filings, most recently posting $513878.0 for Q4 2025.
- Quarterly Treasury Shares rose 20.26% year-over-year to $513878.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $513878.0 (up 20.26% YoY) and the FY2025 annual result came in at $513878.0, up 20.26% from the prior year.
- Treasury Shares improved to $513878.0 in Q4 2025, from $427310.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $4.7 million in Q4 2023 and troughed at $141610.0 in Q1 2021.
- A 5-year average of $1.8 million and a median of $470594.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares slumped 91.07% — and 2023, when it surged 1087.47%.
- Tracing BMRN's Treasury Shares over 5 years: stood at $4.4 million in 2021, then sank by 91.07% to $396120.0 in 2022, then jumped by 1087.47% to $4.7 million in 2023, then slumped by 90.92% to $427310.0 in 2024, then increased by 20.26% to $513878.0 in 2025.
- Business Quant data shows BMRN's Treasury Shares at $513878.0 in Q4 2025, $427310.0 in Q4 2024, and $4.7 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 10.52 Bn | 8.29 Bn | 571.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 513,878.00 |
| Dec 31, 2025 | 513,878.00 |
| Dec 31, 2024 | 427,310.00 |
| Dec 31, 2024 | 427,310.00 |
| Dec 31, 2023 | 4.70 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Dec 31, 2022 | 396,120.00 |
| Dec 31, 2022 | 396,120.00 |
| Dec 31, 2021 | 4.44 Mn |
| Dec 31, 2021 | 4.44 Mn |
| Mar 31, 2021 | 141,610.00 |
| Mar 31, 2021 | 141,610.00 |
| Dec 31, 2020 | 518,000.00 |
| Dec 31, 2020 | 518,000.00 |
| Sep 30, 2020 | 518,000.00 |
| Sep 30, 2020 | 518,000.00 |
| Jun 30, 2020 | 518,000.00 |
| Jun 30, 2020 | 518,000.00 |
| Mar 31, 2020 | 63,400.00 |
| Mar 31, 2020 | 63,400.00 |